Efficacy of tianeptine in the long-term treatment of unipolar major recurrent depressions;Interet de la tianeptine dans le traitement des depressions majeures unipolaires recurrentes. Etude versus placebo sur 16 mois et de demi de traitement

Encephale

Volumn 23, Issue 1, 1997, Pages 56-64

  Dalery J ^a   Dagens Lafont, V ^b   De Bodinat, C ^c  

^a UNIVERSITÉ LYON 1   (France)

^b IRIS Institut de Recherches Internationales Servier   (France)

^c FOCH HOSPITAL   (France)

Author keywords

major depression; recurrences; relapses; tianeptine

Indexed keywords

PLACEBO; TIANEPTINE; THIAZEPINE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; AGED; MIDDLE AGED; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; FEMALE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PERSONALITY INVENTORY; RECURRENCE; THIAZEPINES; TREATMENT OUTCOME;

EID: 0030939231     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. ALTSHULER LL, POST RM, LEVERICH GS et al. Antidepressant. Induced Mania and Cycle Acceleration : A controversy Revisited. Am J Psychiatry 1995 ; 152 : 1130-8.
2. ANGST J, J KUPFER D, ROSENBAUM JF. Recovery from depression : risk or reality ? Acta Psychiatr Scand 1996 ; 93 : 413-9.
3. GAILLARD V. Évaluation des chimiothérapies au long cours dans les dépressions récurrentes. Rouillon. Duphar Upjohn. Ed JP Goureau 1995 : 305-19.
4. CASSANO GB, HEINZE G, LOO H et al. A double-blind comparison of tianeptine, imipramine and placebo in the treatment of majordepressive episodes. Eur Psychiatry 1996 ; 11 : 254-9.
5. COSTA E SILVA JA, RUSCHEL SI, ROCHA FL et al. Placebo-controlled study of tianeptine in major depressive episodes. Neuropsychobiology (In press).
6. DALERY S, SECHTER D. Traitement prolongé par antidépresseur. Encéphale 1994 ; 20 : 209-14.
7. DANION JM. Méthodologie des essais d'antidépresseurs au long cours. In Caillard V, Colonna L. Eds. Rouen : FUAG 27 octobre 1990 : 55-60.
8. DOOGAN DP, CAILLARD V. Sertraline in the prevention of depression. Br J Psychiatry 1992 ; 160 : 217-22.
9. FRANK E, PRIEN RF, JARRETT RB et al. Conceptualisation and rational for consensus. Definitions of terms in major depressive disorder. Arch Gen Psychiatry 1991 ; 48 : 851-5.
10. GUY W. ECDEU assessment manuel for psychopharmacology. Washington, De US. department of health, Education and Welfare 1976 : 217-22.
11. HAMILTON M. A rating scale for depression. J Neurol, Neurosurg and Psychiatry 1960 ; 23 : 56-62.
12. HILL C, COM-NOUGUE C, KRAMAR A et al. Analyse statistique des données de survie. Paris : INSERM. Flammarion Médecine Sciences, 1990.
13. KELLER MB, LAVORI W, LEWIS CE, KLERMAN GL. Predictors of relapse in major depressive disorder. JAMA 1983 ; 250 (24) : 3299-304.
14. LÔO H, GANRY H, DUFOUR H et al. Rôle de la tianeptine dans la prévention des rechutes et récidives dépressives. Premières estimations. Presse Med 1991 ; 20 (37) : 1864-8.
15. MONTGOMERY SA, DUFOUR S, BRION S et al. The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry 1988 ; 153 (suppl.3) : 75-84.
16. MONTGOMERY SA, DUNBAR G. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int Clin Psychopharmacol 1993 ; 8 : 189-95.
17. MONTGOMERY SA, MONTGOMERY DB. Prophylactic treatment in recurrent unipolar depression in long-term treatment of depression (ed Montgomery SA, Rouillon F). J Wiley et sons, 1992 : 53-80.
18. MONTGOMERY SA, RASMUSSEN JGC. Citalopram 20 mg, Citalopram 40 mg and placebo in the prevention of relapse of major depression. Int Clin Psychopharmacol 1991 ; 6 (suppl. 5) : 71-75.
19. NIH/NIMH. Consensus development conference Statement. Mood disorders : Pharmacologic prevention of recurrences. Am J Psychiatry 1995 ; 142/4 : 469-76.
20. PEDERSEN V. Long term studies in Depression - relapse versus remission. Long term studies with antidepressants. Methodological aspects for consideration. Eur Psychiatry 1996 ; 11 : 116-9.
21. PRIEN RF, KLETT CJ, CAFFEY EM. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arc Gen Psychiatry ; 1973 (29) : 420-5.
22. PRIEN RF, KUPFER DJ. Continuation drug therapy for major depressive episodes : how long should it be maintained ? Am J Psychiatry 1986 ; 143 : 18-23.
23. PRIEN RF, KUPFER DJ, MANSKY PA et al. Drug therapy in the prevention of recurrences in Unipolar and Bipolar Affective Disorder. Arch Gen Psychiatry 1984 ; 41 : 1096-104.
24. ROUILLON F, PHILIPPS R, SERRURIER D et al. Rechutes de dépression unipolaire et efficacité de la maprotiline. Encephale 1989 ; 15 : 527-534.
25. ROUILLON F, STERU L, WOOD S. Methodological approaches to the long-term study of antidepressants. Eur Psychiatry 1996 ; 11 : 109-15
26. WILDE MI, BENFIED P. Tianeptine : a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the depression and coexisting anxiety and depression. Drugs 1995; 49 (3) : 411-39.
27. WHO Mental Health Collaborating Centre : consensus statement. J Affective Disord 1989 ; 17 : 197-8.